Filter

Refine by collections

  • Advances and Future Directions in Pheochromocytoma and Paraganglioma (6)

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 6 of 6 items for :

  • molecular markers x
  • Advances and Future Directions in Pheochromocytoma and Paraganglioma x
  • Refine by access: All content x
Clear All
David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed Close
,
Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed Close
,
Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

maximize the risk–benefit balance. Molecular imaging is a component of PM by complementing morphologic imaging in the diagnosis and staging of PPGL, providing predictive and prognostic biomarkers, and implementing therapeutic options. Nuclear medicine is

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0375
Volume/Issue:
Volume 30: Issue 4
Free access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed Close

, for example, enabled the simultaneous measurement of several amines with increased assay sensitivity for 3-methoxytyramine by LC-MS/MS (van Faassen et al. 2020). The use of such extended metabolite panels might identify further markers for patient

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0376
Volume/Issue:
Volume 30: Issue 6
Open access
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed Close

. From a molecular perspective, WHO experts report that germline mutations in SDHB confer the highest risk of metastasis and that mutations in ATRX , or SETD2 , high total somatic mutation burden, MAML3 fusion genes, altered WNT pathway, and TERT

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0373
Volume/Issue:
Volume 30: Issue 4
Open access
Arthur S Tischler Department of Pathology and Laboratory Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA

Search for other papers by Arthur S Tischler in
Google Scholar
PubMed Close
and
Judith Favier Université Paris cité, Inserm UMR970 PARCC, Equipe Labellisée par la Ligue contre le cancer, Paris, France

Search for other papers by Judith Favier in
Google Scholar
PubMed Close

cultures raise particular questions about how studies should optimally be performed and how cytotoxicity should be assessed. Approaches range from monolayer culture and counting of cells stained for neuroendocrine markers, a method first used effectively a

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0405
Volume/Issue:
Volume 30: Issue 5
Free access
Paul Benjamin Loughrey Patrick G Johnston Centre for Cancer Research, Queen’s University, Belfast, UK
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed Close
,
Federico Roncaroli Geoffrey Jefferson Brain Research Centre, Division of Neuroscience and Experimental Psychology, School of Medicine, Manchester University, Manchester, UK

Search for other papers by Federico Roncaroli in
Google Scholar
PubMed Close
,
Estelle Healy Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Estelle Healy in
Google Scholar
PubMed Close
,
Philip Weir Department of Neurosurgery, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Philip Weir in
Google Scholar
PubMed Close
,
Madhu Basetti Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK

Search for other papers by Madhu Basetti in
Google Scholar
PubMed Close
,
Ruth T Casey Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed Close
,
Steven J Hunter Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Steven J Hunter in
Google Scholar
PubMed Close
, and
Márta Korbonits Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed Close

coincidental. Succinate dehydrogenase (SDH) gene variants (collectively known as SDHx ) can associate with PPGL ( Baysal et al. 2000 ). The association of PitNET and PPGL in the setting of SDHx variant was established at the molecular level in 2012

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0157
Volume/Issue:
Volume 29: Issue 10
Open access
Francesca Amore Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

Search for other papers by Francesca Amore in
Google Scholar
PubMed Close
,
Rachele Garella Department Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Rachele Garella in
Google Scholar
PubMed Close
,
Alice Santi Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

Search for other papers by Alice Santi in
Google Scholar
PubMed Close
,
Daniele Guasti Department of Experimental and Clinical Medicine, Imaging Platform, University of Florence, Italy

Search for other papers by Daniele Guasti in
Google Scholar
PubMed Close
,
Serena Martinelli Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Serena Martinelli in
Google Scholar
PubMed Close
,
Letizia Canu Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Letizia Canu in
Google Scholar
PubMed Close
,
Daniele Bani Department of Experimental and Clinical Medicine, Imaging Platform, University of Florence, Italy

Search for other papers by Daniele Bani in
Google Scholar
PubMed Close
,
Jiri Neuzil Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic
School of Pharmacy and Medical Science, Griffith University, Southport, Queensland, Australia
Faculty of Science and 1st Medical Faculty, Charles University, Prague, Czech Republic

Search for other papers by Jiri Neuzil in
Google Scholar
PubMed Close
,
Mario Maggi Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Mario Maggi in
Google Scholar
PubMed Close
,
Roberta Squecco Department Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Roberta Squecco in
Google Scholar
PubMed Close
, and
Elena Rapizzi Department Experimental and Clinical Medicine, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Elena Rapizzi in
Google Scholar
PubMed Close

markers of EMT, such as Twist1 , Snai1 , Snai2 and Vimentin , was significantly increased in SDHB-deficient cells ( Fig. 2C ), suggesting that these cells undergo a transcriptional reprogramming associated with an EMT phenotype. Membrane

Article Type:
Research Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-23-0167
Volume/Issue:
Volume 30: Issue 10
Restricted access